0001209191-22-020081.txt : 20220318 0001209191-22-020081.hdr.sgml : 20220318 20220318173607 ACCESSION NUMBER: 0001209191-22-020081 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220207 FILED AS OF DATE: 20220318 DATE AS OF CHANGE: 20220318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Timothy B CENTRAL INDEX KEY: 0001661983 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36030 FILM NUMBER: 22753622 MAIL ADDRESS: STREET 1: C/O MARRONE BIO INNOVATIONS, INC. STREET 2: 1540 DREW AVENUE CITY: DAVIS STATE: CA ZIP: 95618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MARRONE BIO INNOVATIONS INC CENTRAL INDEX KEY: 0001441693 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 205137161 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7780-420 BRIER CREEK PARKWAY STREET 2: RALEIGH CITY: RALEIGH STATE: 1W ZIP: 27617 BUSINESS PHONE: 530-750-2800 MAIL ADDRESS: STREET 1: 7780-420 BRIER CREEK PARKWAY STREET 2: RALEIGH CITY: RALEIGH STATE: 1W ZIP: 27617 FORMER COMPANY: FORMER CONFORMED NAME: MARRONE ORGANICS INNOVATIONS INC DATE OF NAME CHANGE: 20080801 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-02-07 2022-02-09 0 0001441693 MARRONE BIO INNOVATIONS INC MBII 0001661983 Johnson Timothy B C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARKWAY RALEIGH NC 27617-7882 0 1 0 0 VP (Field and Technical) Common Stock 2022-02-07 4 A 0 66623 0.6321 A 105156 D Stock Option (Right to Buy) 0.6321 2022-02-07 4 A 0 155455 0.00 A 2022-03-07 2032-02-07 Common Stock 155455 155455 D On February 7, the reporting person was granted 66,623 restricted stock units, which represent a contingent right to receive one share of Issuer's common stock. The restricted stock units vest pursuant to the Vesting Schedule (as defined in footnote (2)) and are delivered to the reporting person upon vesting. The awards vest in equal monthly installments over three years, subject to the recipient's continued employment by the Issuer through the applicable vesting date, provided that, in lieu of the terms of any change in control agreement in place between the Issuer and the reporting person, in the event that the reporting person resigns for Good Reason (as defined in the recipient's change in control agreement) or is terminated without Cause (as defined in recipient's change in control agreement) within twelve months of a Change in Control (as defined in recipient's change in control agreement), 50% of the unvested portion of the awards will become immediately vested (the "Vesting Schedule"). The original Form 4, filed on February 9, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misstated the expiration date as February 6, 2025. /s/ Linda V. Moore, as attorney in fact 2022-03-18